{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:27:31Z","timestamp":1792848451903,"version":"4.5.0"},"reference-count":249,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["1-2516-FSB-416"],"award-info":[{"award-number":["1-2516-FSB-416"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Yellow fever virus (YFV) represents a re-emerging zoonotic pathogen, transmitted by mosquito vectors to humans from primate reservoirs. Sporadic outbreaks of YFV occur in endemic tropical regions, causing a viral hemorrhagic fever (VHF) associated with high mortality rates. Despite a highly effective vaccine, no antiviral treatments currently exist. Therefore, YFV represents a neglected tropical disease and is chronically understudied, with many aspects of YFV biology incompletely defined including host range, host\u2013virus interactions and correlates of host immunity and pathogenicity. In this article, we review the current state of YFV research, focusing on the viral lifecycle, host responses to infection, species tropism and the success and associated limitations of the YFV-17D vaccine. In addition, we highlight the current lack of available treatments and use publicly available sequence and structural data to assess global patterns of YFV sequence diversity and identify potential drug targets. Finally, we discuss how technological advances, including real-time epidemiological monitoring of outbreaks using next-generation sequencing and CRISPR\/Cas9 modification of vector species, could be utilized in future battles against this re-emerging pathogen which continues to cause devastating disease.<\/jats:p>","DOI":"10.3390\/v11100960","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:07:59Z","timestamp":1571310479000},"page":"960","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-7410","authenticated-orcid":false,"given":"Robin","family":"Kleinert","sequence":"first","affiliation":[{"name":"Division of Veterinary Medicine, Paul-Ehrlich-Institute, 63225 Langen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-8565","authenticated-orcid":false,"given":"Eduardo","family":"Montoya-Diaz","sequence":"additional","affiliation":[{"name":"Division of Veterinary Medicine, Paul-Ehrlich-Institute, 63225 Langen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-3197","authenticated-orcid":false,"given":"Tanvi","family":"Khera","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Welsch","sequence":"additional","affiliation":[{"name":"University of Veterinary Medicine Hannover, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-0707","authenticated-orcid":false,"given":"Birthe","family":"Tegtmeyer","sequence":"additional","affiliation":[{"name":"Institute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-9385","authenticated-orcid":false,"given":"Sebastian","family":"Hoehl","sequence":"additional","affiliation":[{"name":"Institute of Medical Virology, University Hospital Frankfurt, 60596 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ciesek","sequence":"additional","affiliation":[{"name":"Institute of Medical Virology, University Hospital Frankfurt, 60596 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-6671","authenticated-orcid":false,"given":"Richard","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Veterinary Medicine, Paul-Ehrlich-Institute, 63225 Langen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/532155a","article-title":"Fears rise over yellow fever\u2019s next move","volume":"532","author":"Butler","year":"2016","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cppeds.2009.01.001","article-title":"Mosquito-borne diseases","volume":"39","author":"Tolle","year":"2009","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"ref_3","first-page":"775","article-title":"A century of progress in combating yellow fever*","volume":"64","year":"1986","journal-title":"Bull. World Health Organ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/smvy.1994.1014","article-title":"Yellow fever and dengue\u2014the interactions of virus, vector and host in the re-emergence of epidemic disease","volume":"5","author":"Monath","year":"1994","journal-title":"Semin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J. Clin. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cll.2010.01.001","article-title":"Yellow fever: A reemerging threat","volume":"30","author":"Gardner","year":"2010","journal-title":"Clin. Lab. Med."},{"key":"ref_7","first-page":"179","article-title":"History of Epidemiological Aspects of Yellow Fever","volume":"55","author":"Downs","year":"1982","journal-title":"Yale J. Biol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The Use of Yellow Fever Virus Modified by in Vitro Cultivation For Human Immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Garske, T., van Kerkhove, M.D., Yactayo, S., Ronveaux, O., Lewis, R.F., Staples, J.E., Perea, W., and Ferguson, N.M. (2014). Yellow Fever in Africa: Estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med., 11.","DOI":"10.1371\/journal.pmed.1001638"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV Virus Taxonomy Profile: Flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3201\/eid2210.160818","article-title":"Resurgence of Yellow Fever in Angola, 2015\u20132016","volume":"22","author":"Grobbelaar","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(16)30513-8","article-title":"Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015\u201316: A modelling study","volume":"17","author":"Kraemer","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMp1702172","article-title":"Yellow Fever\u2014Once Again on the Radar Screen in the Americas","volume":"376","author":"Paules","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.aau8225","article-title":"The reemergence of yellow fever","volume":"361","author":"Barrett","year":"2018","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1126\/science.aat7115","article-title":"Genomic and epidemiological monitoring of yellow fever virus transmission potential","volume":"361","author":"Faria","year":"2018","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Dorigatti, I., Hamlet, A., Aguas, R., Cattarino, L., Cori, A., Donnelly, C.A., Garske, T., Imai, N., and Ferguson, N.M. (2017). International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017. Euro Surveill., 22.","DOI":"10.2807\/1560-7917.ES.2017.22.28.30572"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: An update","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","first-page":"285","article-title":"Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation","volume":"1","author":"Rice","year":"1989","journal-title":"New Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1099\/vir.0.80746-0","article-title":"Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes","volume":"86","author":"McElroy","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2014.12.007","article-title":"Flavivirus reverse genetic systems, construction techniques and applications: A historical perspective","volume":"114","author":"Aubry","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1073\/pnas.1814484116","article-title":"Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers","volume":"116","author":"Furuse","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Klitting, R., Fischer, C., Drexler, J.F., Gould, E.A., Roiz, D., Paupy, C., and de Lamballerie, X. (2018). What Does the Future Hold for Yellow Fever Virus? (II). Genes, 9.","DOI":"10.20944\/preprints201807.0378.v1"},{"key":"ref_28","unstructured":"Centers for Disease Control and Prevention (2019, August 12). Yellow Fever\u2014Clinical and Laboratory Evaluation, Available online: https:\/\/www.cdc.gov\/yellowfever\/healthcareproviders\/healthcareproviders-clinlabeval.html."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trstmh.2006.02.019","article-title":"Hepatocyte lesions and cellular immune response in yellow fever infection","volume":"101","author":"Quaresma","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e01253-14","DOI":"10.1128\/mBio.01253-14","article-title":"Human genetic variation and yellow fever mortality during 19th century U.S. epidemics","volume":"5","author":"Blake","year":"2014","journal-title":"MBio"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: Analysis of reported cases 1998-2002","volume":"101","author":"Tuboi","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e190098","DOI":"10.1590\/0074-02760190098","article-title":"Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses","volume":"114","author":"Oliveira","year":"2019","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41598-017-06612-2","article-title":"Evaluation of Sofosbuvir (\u03b2-D-2\u2019-deoxy-2\u2019-\u03b1-fluoro-2\u2019-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"De Freitas, C.S., Higa, L.M., Sacramento, C.Q., Ferreira, A.C., Reis, P.A., Delvecchio, R., Monteiro, F.L., Barbosa-Lima, G., James Westgarth, H., and Vieira, Y.R. (2019). Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007072"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.00074-09","article-title":"Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay","volume":"53","author":"Patkar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1128\/JVI.01253-16","article-title":"A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein","volume":"90","author":"Guo","year":"2016","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11262-009-0328-3","article-title":"RNA interference inhibits yellow fever virus replication in vitro and in vivo","volume":"38","author":"Pacca","year":"2009","journal-title":"Virus Genes"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2012.12.002","article-title":"Experimental therapies for yellow fever","volume":"97","author":"Julander","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S1462399408000665","article-title":"Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection","volume":"10","author":"Pierson","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coviro.2012.12.001","article-title":"Flaviviruses: Braking the entering","volume":"3","author":"Pierson","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/JVI.02120-06","article-title":"Functional requirements of the yellow fever virus capsid protein","volume":"81","author":"Patkar","year":"2007","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1128\/JVI.78.22.12591-12602.2004","article-title":"The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals","volume":"78","author":"Caron","year":"2004","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virol.2005.09.036","article-title":"Class II virus membrane fusion proteins","volume":"344","author":"Kielian","year":"2006","journal-title":"Virology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-422X-5-27","article-title":"Constancy and diversity in the flavivirus fusion peptide","volume":"5","author":"Seligman","year":"2008","journal-title":"Virol. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2009.09.001","article-title":"Structure of yellow fever virus envelope protein domain III","volume":"394","author":"Volk","year":"2009","journal-title":"Virology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1998.9057","article-title":"Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice","volume":"244","author":"Ryman","year":"1998","journal-title":"Virology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2005.04.031","article-title":"Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: Characterization with human monoclonal antibody fragments and neutralization escape variants","volume":"337","author":"Daffis","year":"2005","journal-title":"Virology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.celrep.2018.12.065","article-title":"Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope","volume":"26","author":"Lu","year":"2019","journal-title":"Cell Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1038\/emi.2016.89","article-title":"A fatal yellow fever virus infection in China: Description and lessons","volume":"5","author":"Chen","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-3527(03)59003-0","article-title":"Flavivirus structure and membrane fusion","volume":"59","author":"Heinz","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"Monath","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1080\/21645515.2017.1337614","article-title":"Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection","volume":"13","author":"Resch","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2515135518800689","article-title":"Broadly neutralizing antibodies in HIV-1 treatment and prevention","volume":"6","author":"Kumar","year":"2018","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/imr.12506","article-title":"HIV antibodies for treatment of HIV infection","volume":"275","author":"Margolis","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Miller, J.L., de Wet, B.J.M., Martinez-Pomares, L., Radcliffe, C.M., Dwek, R.A., Rudd, P.M., and Gordon, S. (2008). The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog., 4.","DOI":"10.1371\/annotation\/98b92fca-fa6e-4bf3-9b39-13b66b640476"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20021840","article-title":"DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells","volume":"197","author":"Tassaneetrithep","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature07207","article-title":"RNA interference screen for human genes associated with West Nile virus infection","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Le Sommer, C., Barrows, N.J., Bradrick, S.S., Pearson, J.L., and Garcia-Blanco, M.A. (2012). G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001820"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","article-title":"The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry","volume":"12","author":"Meertens","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/viro.2001.1232","article-title":"Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus","volume":"292","author":"Germi","year":"2002","journal-title":"Virology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0042-6822(02)00097-1","article-title":"Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus","volume":"308","author":"Kroschewski","year":"2003","journal-title":"Virology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)80058-6","article-title":"A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry","volume":"99","author":"Shukla","year":"1999","journal-title":"Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/aid.1993.9.167","article-title":"Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines","volume":"9","author":"Patel","year":"1993","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antivir. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v6010069","article-title":"Flavivirus entry receptors: An update","volume":"6","author":"Meertens","year":"2013","journal-title":"Viruses"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","article-title":"Dengue virus life cycle: Viral and host factors modulating infectivity","volume":"67","author":"Wilschut","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nature07967","article-title":"Discovery of insect and human dengue virus host factors","volume":"458","author":"Sessions","year":"2009","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e01348-16","DOI":"10.1128\/JVI.01348-16","article-title":"mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes","volume":"91","author":"Liu","year":"2017","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2010.07.038","article-title":"A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes","volume":"142","author":"Cheng","year":"2010","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Fernandez-Garcia, M.D., Meertens, L., Chazal, M., Hafirassou, M.L., Dejarnac, O., Zamborlini, A., Despres, P., Sauvonnet, N., Arenzana-Seisdedos, F., and Jouvenet, N. (2016). Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses. MBio, 7.","DOI":"10.1128\/mBio.01956-15"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"21785","DOI":"10.1074\/jbc.R000003200","article-title":"Ligand binding to integrins","volume":"275","author":"Plow","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1128\/JVI.75.22.10912-10922.2001","article-title":"Neuroadapted Yellow Fever Virus 17D: Genetic and Biological Characterization of a Highly Mouse-Neurovirulent Virus and Its Infectious Molecular Clone","volume":"75","author":"Chambers","year":"2001","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt.3179","article-title":"Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody","volume":"33","author":"Mailly","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Campos, R.K., Wong, B., Xie, X., Lu, Y.-F., Shi, P.-Y., Pompon, J., Garcia-Blanco, M.A., and Bradrick, S.S. (2017). RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation. J. Virol., 91.","DOI":"10.1128\/JVI.01706-16"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1128\/jvi.65.11.6042-6050.1991","article-title":"Processing of the yellow fever virus nonstructural polyprotein: A catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites","volume":"65","author":"Chambers","year":"1991","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1099\/vir.0.80427-0","article-title":"Yellow fever virus NS2B-NS3 protease: Characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities","volume":"86","author":"Chambers","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lindenbach, B.D., and Rice, C.M. (2003). Molecular Biology of Flaviviruses, Elsevier.","DOI":"10.1016\/S0065-3527(03)59002-9"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1101\/gad.1444206","article-title":"A 5\u2032 RNA element promotes dengue virus RNA synthesis on a circular genome","volume":"20","author":"Filomatori","year":"2006","journal-title":"Genes Dev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2007.12.035","article-title":"Specific requirements for elements of the 5\u2032 and 3\u2032 terminal regions in flavivirus RNA synthesis and viral replication","volume":"374","author":"Yu","year":"2008","journal-title":"Virology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/viro.1993.1587","article-title":"The NS3 nonstructural protein of flaviviruses contains an RNA triphosphatase activity","volume":"197","author":"Wengler","year":"1993","journal-title":"Virology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: Crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.02704-06","article-title":"Structure and function of flavivirus NS5 methyltransferase","volume":"81","author":"Zhou","year":"2007","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1261\/rna.1609709","article-title":"The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure","volume":"15","author":"Issur","year":"2009","journal-title":"RNA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1128\/JVI.00118-14","article-title":"Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells","volume":"88","author":"Junjhon","year":"2014","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.87.22.8898","article-title":"Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein","volume":"87","author":"Chambers","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1128\/jvi.71.9.6650-6661.1997","article-title":"Ultrastructure of Kunjin virus-infected cells: Colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures","volume":"71","author":"Westaway","year":"1997","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.1996.0067","article-title":"Recombinant Dengue Type 1 Virus NS5 Protein Expressed inEscherichia coliExhibits RNA-Dependent RNA Polymerase Activity","volume":"216","author":"Tan","year":"1996","journal-title":"Virology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"19100","DOI":"10.1074\/jbc.270.32.19100","article-title":"Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5","volume":"270","author":"Kapoor","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.virol.2008.07.013","article-title":"Phosphorylation of yellow fever virus NS5 alters methyltransferase activity","volume":"380","author":"Bhattacharya","year":"2008","journal-title":"Virology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1128\/JVI.76.10.4773-4784.2002","article-title":"Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles","volume":"76","author":"Rice","year":"2002","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1128\/JVI.00002-08","article-title":"Role of nonstructural protein NS2A in flavivirus assembly","volume":"82","author":"Leung","year":"2008","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/JVI.01900-12","article-title":"An N-terminal amphipathic helix in dengue virus nonstructural protein 4A mediates oligomerization and is essential for replication","volume":"87","author":"Stern","year":"2013","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/viro.1998.9156","article-title":"Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A","volume":"245","author":"Mackenzie","year":"1998","journal-title":"Virology"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Kaufusi, P.H., Kelley, J.F., Yanagihara, R., and Nerurkar, V.R. (2014). Induction of endoplasmic reticulum-derived replication-competent membrane structures by West Nile virus non-structural protein 4B. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084040"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1099\/0022-1317-72-6-1331","article-title":"Characterization of yellow fever virus proteins E and NS1 expressed in Vero and Spodoptera frugiperda cells","volume":"72","author":"Girard","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2014.09.020","article-title":"Coupling of replication and assembly in flaviviruses","volume":"9","author":"Sirohi","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/JVI.75.10.4633-4640.2001","article-title":"Coupling between replication and packaging of flavivirus RNA: Evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus","volume":"75","author":"Khromykh","year":"2001","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/wrna.1191","article-title":"Regulation of flavivirus RNA synthesis and capping","volume":"4","author":"Saeedi","year":"2013","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.febslet.2011.06.038","article-title":"RNA binding property and RNA chaperone activity of dengue virus core protein and other viral RNA-interacting proteins","volume":"585","author":"Pong","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1099\/vir.0.18723-0","article-title":"Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus","volume":"84","author":"Elshuber","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","article-title":"Revisiting the liver in human yellow fever: Virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity","volume":"345","author":"Quaresma","year":"2006","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"Sakho","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/517806","article-title":"In Vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination","volume":"3","author":"Hacker","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1038\/s41598-018-29235-7","article-title":"Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons","volume":"8","author":"Sinigaglia","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon","volume":"16","author":"Morrison","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Cong, Y., McArthur, M.A., Cohen, M., Jahrling, P.B., Janosko, K.B., Josleyn, N., Kang, K., Zhang, T., and Holbrook, M.R. (2016). Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004709"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coi.2004.11.001","article-title":"NK cells in innate immunity","volume":"17","author":"Hamerman","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41541-017-0039-z","article-title":"Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204","volume":"3","author":"Lam","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1038\/ncomms14781","article-title":"Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome","volume":"8","author":"Douam","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Neves, P.C.C., Santos, J.R., Tubar\u00e3o, L.N., Bonaldo, M.C., and Galler, R. (2013). Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081953"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.1401811","article-title":"The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education","volume":"195","author":"Marquardt","year":"2015","journal-title":"J. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The roles of TLRs, RLRs and NLRs in pathogen recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Suthar, M.S., Aguirre, S., and Fernandez-Sesma, A. (2013). Innate immune sensing of flaviviruses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003541"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6106582","DOI":"10.1155\/2018\/6106582","article-title":"Toll-Like Receptors and RIG-I-Like Receptors Play Important Roles in Resisting Flavivirus","volume":"2018","author":"Guo","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.03114-13","article-title":"Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response","volume":"88","author":"Olagnier","year":"2014","journal-title":"J. Virol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/JVI.01305-07","article-title":"Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1","volume":"82","author":"Fredericksen","year":"2008","journal-title":"J. Virol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/srep00347","article-title":"STING mediates neuronal innate immune response following Japanese encephalitis virus infection","volume":"2","author":"Nazmi","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2015.06.015","article-title":"A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2\u2019O-Methylated Self RNA","volume":"43","author":"Ludwig","year":"2015","journal-title":"Immunity"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature12862","article-title":"Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity","volume":"505","author":"Schoggins","year":"2014","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1038\/nmicrobiol.2017.50","article-title":"Viral pathogenesis: Dengue virus takes on cGAS","volume":"2","author":"Gack","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"17037","DOI":"10.1038\/nmicrobiol.2017.37","article-title":"Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection","volume":"2","author":"Aguirre","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"E6310","DOI":"10.1073\/pnas.1803406115","article-title":"Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease","volume":"115","author":"Ding","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.1100229","article-title":"Modulation of inflammasome pathways by bacterial and viral pathogens","volume":"187","author":"Lamkanfi","year":"2011","journal-title":"J. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Yi, Z., Sperzel, L., N\u00fcrnberger, C., Bredenbeek, P.J., Lubick, K.J., Best, S.M., Stoyanov, C.T., Law, L.M.J., Yuan, Z., and Rice, C.M. (2011). Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001255"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41564-018-0244-1","article-title":"A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication","volume":"3","author":"Richardson","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.trstmh.2003.12.003","article-title":"Wild terrestrial rainforest mammals as potential reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis encephalitis viruses) in French Guiana","volume":"98","author":"Dussart","year":"2004","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.coviro.2016.03.010","article-title":"Animal models of yellow fever and their application in clinical research","volume":"18","author":"Julander","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell Res."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Strick-Marchand, H., Dusseaux, M., Darche, S., Huntington, N.D., Legrand, N., Masse-Ranson, G., Corcuff, E., Ahodantin, J., Weijer, K., and Spits, H. (2015). A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119820"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1099\/0022-1317-67-4-631","article-title":"Comparison of neurovirulence of different strains of yellow fever virus in mice","volume":"67","author":"Barrett","year":"1986","journal-title":"J. Gen. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Almeida, M.A.B., Cardoso, J.d.C., Dos Santos, E., da Fonseca, D.F., Cruz, L.L., Faraco, F.J.C., Bercini, M.A., Vettorello, K.C., Porto, M.A., and Mohrdieck, R. (2014). Surveillance for yellow Fever virus in non-human primates in southern Brazil, 2001\u20132011: A tool for prioritizing human populations for vaccination. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002741"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2015.09.019","article-title":"Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system","volume":"487","author":"Luethy","year":"2016","journal-title":"Virology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.3390\/v7072795","article-title":"Tissue Barriers to Arbovirus Infection in Mosquitoes","volume":"7","author":"Franz","year":"2015","journal-title":"Viruses"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Danet, L., Beauclair, G., Berthet, M., Moratorio, G., Gracias, S., Tangy, F., Choumet, V., and Jouvenet, N. (2019). Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti. PLoS Negl. Trop. Dis.","DOI":"10.1101\/577213"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.1128\/JVI.02149-13","article-title":"Dynamic viral dissemination in mice infected with yellow fever virus strain 17D","volume":"87","author":"Erickson","year":"2013","journal-title":"J. Virol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e00819-17","DOI":"10.1128\/mBio.00819-17","article-title":"Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo","volume":"8","author":"Douam","year":"2017","journal-title":"MBio"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Meier, K.C., Gardner, C.L., Khoretonenko, M.V., Klimstra, W.B., and Ryman, K.D. (2009). A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000614"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Miorin, L., Laurent-Rolle, M., Pisanelli, G., Co, P.H., Albrecht, R.A., Garcia-Sastre, A., and Morrison, J. (2019). Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism. J. Virol., 93.","DOI":"10.1128\/JVI.00151-19"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4161\/21645515.2014.981115","article-title":"The polio endgame","volume":"10","author":"Minor","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/rmv.311","article-title":"The transmission of yellow fever to Macacus rhesus","volume":"11","author":"Stokes","year":"2001","journal-title":"Rev. Med. Virol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14712598.8.11.1787","article-title":"Yellow fever vaccine: Past, present and future","volume":"8","author":"Roukens","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14760584.2018.1406800","article-title":"The 17D-204 and 17DD yellow fever vaccines: An overview of major similarities and subtle differences","volume":"17","author":"Ferreira","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1016\/j.vaccine.2017.03.032","article-title":"Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease","volume":"35","author":"Barrett","year":"2017","journal-title":"Vaccine"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4161\/hv.26549","article-title":"Yellow fever vaccine: An effective vaccine for travelers","volume":"10","author":"Verma","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_162","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Collaborative Group for Studies on Yellow Fever Vaccines (2014). Duration of post-vaccination immunity against yellow fever in adults. Vaccine, 32, 4977\u20134984.","DOI":"10.1016\/j.vaccine.2014.07.021"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: Systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J. Med. Virol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Wieten, R.W., Jonker, E.F.F., van Leeuwen, E.M.M., Remmerswaal, E.B.M., ten Berge, I.J.M., de Visser, A.W., van Genderen, P.J.J., Goorhuis, A., Visser, L.G., and Grobusch, M.P. (2016). A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149871"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: Neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop. Med. Int. Health"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Watson, A.M., and Klimstra, W.B. (2017). T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models. Viruses, 9.","DOI":"10.3390\/v9040077"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"TLR expression and NK cell activation after human yellow fever vaccination","volume":"27","author":"Matos","year":"2009","journal-title":"Vaccine"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.4269\/ajtmh.13-0443a","article-title":"17D Yellow Fever Virus Vaccine","volume":"89","author":"Monath","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: Protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","article-title":"Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development","volume":"28","author":"Franco","year":"2010","journal-title":"Vaccine"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2010.04.071","article-title":"Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii","volume":"28","author":"Stoyanov","year":"2010","journal-title":"Vaccine"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","article-title":"The yellow fever 17D virus as a platform for new live attenuated vaccines","volume":"10","author":"Bonaldo","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","article-title":"Current status and future prospects of yellow fever vaccines","volume":"14","author":"Beck","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"335","DOI":"10.15585\/mmwr.mm6612a5","article-title":"Yellow Fever Outbreak - Kongo Central Province, Democratic Republic of the Congo, August 2016","volume":"66","author":"Otshudiema","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMp1803433","article-title":"Fractional-Dose Yellow Fever Vaccination\u2014Advancing the Evidence Base","volume":"379","author":"Vannice","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1606997","article-title":"Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand","volume":"375","author":"Barrett","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bjid.2017.02.004","article-title":"Yellow fever outbreak in Brazil, 2017","volume":"21","author":"Goldani","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e180278","DOI":"10.1590\/0074-02760180278","article-title":"Yellow fever outbreak in Brazil: The puzzle of rapid viral spread and challenges for immunisation","volume":"113","author":"Possas","year":"2018","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/2051013613498954","article-title":"Advances and controversies in yellow fever vaccination","volume":"1","author":"Jonker","year":"2013","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1586\/14760584.2014.923761","article-title":"Tools and approaches to ensure quality of vaccines throughout the cold chain","volume":"13","author":"Kartoglu","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1016\/j.vaccine.2011.07.054","article-title":"Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines","volume":"29","author":"Wiggan","year":"2011","journal-title":"Vaccine"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1128\/JVI.03402-13","article-title":"Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity","volume":"88","author":"Schotte","year":"2014","journal-title":"J. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41591-019-0510-7","article-title":"Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection","volume":"25","author":"Chan","year":"2019","journal-title":"Nat. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.vaccine.2011.04.055","article-title":"Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review","volume":"29","author":"Thomas","year":"2011","journal-title":"Vaccine"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.26633\/RPSP.2018.75","article-title":"Yellow fever vaccine and risk of developing serious adverse events: A systematic review","volume":"42","author":"Porudominsky","year":"2018","journal-title":"Rev. Panam Salud Publica"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/596209","article-title":"Response to \u201cCase of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"199","author":"Colebunders","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Hernandez, N., Bucciol, G., Moens, L., Le Pen, J., Shahrooei, M., Goudouris, E., Shirkani, A., Changi-Ashtiani, M., Rokni-Zadeh, H., and Sayar, E.H. (2019). Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. J. Exp. Med.","DOI":"10.1084\/jem.20182295"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3201\/eid2210.160875","article-title":"Yellow Fever-More a Policy and Planning Problem than a Biological One","volume":"22","author":"Calisher","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_199","unstructured":"World Health Organization (2018). A Global Strategy to Eliminate Yellow Fever Epidemics 2017\u20132026, World Health Organization."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4269\/ajtmh.16-0401","article-title":"A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination","volume":"95","author":"Jean","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Zhao, S., Stone, L., Gao, D., and He, D. (2018). Modelling the large-scale yellow fever outbreak in Luanda, Angola, and the impact of vaccination. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006158"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.vaccine.2019.01.074","article-title":"POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa","volume":"37","author":"Hamlet","year":"2019","journal-title":"Vaccine"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Schafer, B., Holzer, G.W., Joachimsthaler, A., Coulibaly, S., Schwendinger, M., Crowe, B.A., Kreil, T.R., Barrett, P.N., and Falkner, F.G. (2011). Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024505"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Maciel, M., Cruz Fda, S., Cordeiro, M.T., da Motta, M.A., Cassemiro, K.M., Maia Rde, C., de Figueiredo, R.C., Galler, R., Freire Mda, S., and August, J.T. (2015). A DNA vaccine against yellow fever virus: Development and evaluation. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003693"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4269\/ajtmh.16-0293","article-title":"Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models","volume":"98","author":"Tottey","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3389\/fimmu.2018.01919","article-title":"Recent Developments in Recombinant Protein-Based Dengue Vaccines","volume":"9","author":"Tripathi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2018.11.003","article-title":"Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants","volume":"70","author":"Khera","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Wong, G. (2019). Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine. MBio, 10.","DOI":"10.1128\/mBio.01597-19"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2017.14258","article-title":"Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever","volume":"318","author":"Chen","year":"2017","journal-title":"JAMA"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/14760584.2016.1175943","article-title":"DNA-launched live-attenuated vaccines for biodefense applications","volume":"15","author":"Pushko","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.1128\/JVI.77.19.10423-10431.2003","article-title":"Recombination in circulating enteroviruses","volume":"77","author":"Lukashev","year":"2003","journal-title":"J. Virol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: Past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"vey021","DOI":"10.1093\/ve\/vey021","article-title":"Exploratory re-encoding of yellow fever virus genome: New insights for the design of live-attenuated viruses","volume":"4","author":"Klitting","year":"2018","journal-title":"Virus Evol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tim.2015.11.002","article-title":"Synonymous Virus Genome Recoding as a Tool to Impact Viral Fitness","volume":"24","author":"Martinez","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Nougairede, A., de Fabritus, L., Aubry, F., Gould, E.A., Holmes, E.C., and de Lamballerie, X. (2013). Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003172"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"de Fabritus, L., Nougairede, A., Aubry, F., Gould, E.A., and de Lamballerie, X. (2015). Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004738"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.meegid.2012.08.015","article-title":"Evolutionary and ecological factors underlying the tempo and distribution of yellow fever virus activity","volume":"13","author":"Carrington","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"W260","DOI":"10.1093\/nar\/gkz303","article-title":"NGPhylogeny.fr: New generation phylogenetic services for non-specialists","volume":"47","author":"Lemoine","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1128\/JVI.79.16.10268-10277.2005","article-title":"Structure of the Flavivirus helicase: Implications for catalytic activity, protein interactions, and proteolytic processing","volume":"79","author":"Wu","year":"2005","journal-title":"J. Virol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/JVI.78.2.1032-1038.2004","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","author":"Pugachev","year":"2004","journal-title":"J. Virol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.7717\/peerj.74","article-title":"A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase","volume":"1","author":"Vlachakis","year":"2013","journal-title":"PeerJ"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrg.2017.88","article-title":"Towards a genomics-informed, real-time, global pathogen surveillance system","volume":"19","author":"Gardy","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Brinkmann, A., Erg\u00fcnay, K., Radoni\u0107, A., Kocak Tufan, Z., Domingo, C., and Nitsche, A. (2017). Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006075"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2011.08.024","article-title":"Using next generation sequencing to identify yellow fever virus in Uganda","volume":"422","author":"McMullan","year":"2012","journal-title":"Virology"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature16996","article-title":"Real-time, portable genome sequencing for Ebola surveillance","volume":"530","author":"Quick","year":"2016","journal-title":"Nature"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aau9343","article-title":"Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak","volume":"363","author":"Kafetzopoulou","year":"2019","journal-title":"Science"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13059-016-1103-0","article-title":"The Oxford Nanopore MinION: Delivery of nanopore sequencing to the genomics community","volume":"17","author":"Jain","year":"2016","journal-title":"Genome Biol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41564-018-0296-2","article-title":"Tracking virus outbreaks in the twenty-first century","volume":"4","author":"Grubaugh","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2016.04.025","article-title":"Yellow fever cases in Asia: Primed for an epidemic","volume":"48","author":"Wasserman","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Chen, C., Jiang, D., Ni, M., Li, J., Chen, Z., Liu, J., Ye, H., Wong, G., Li, W., and Zhang, Y. (2018). Phylogenomic analysis unravels evolution of yellow fever virus within hosts. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006738"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/JVI.01738-09","article-title":"Yellow fever virus exhibits slower evolutionary dynamics than dengue virus","volume":"84","author":"Sall","year":"2010","journal-title":"J. Virol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2014.12.003","article-title":"Reservoir host immune responses to emerging zoonotic viruses","volume":"160","author":"Mandl","year":"2015","journal-title":"Cell"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Lequime, S., Paul, R.E., and Lambrechts, L. (2016). Determinants of Arbovirus Vertical Transmission in Mosquitoes. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005548"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4269\/ajtmh.2000.62.151","article-title":"Vertical transmission of the yellow fever virus by Aedes aegypti (Diptera, Culicidae): Dynamics of infection in F1 adult progeny of orally infected females","volume":"62","author":"Diallo","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Amraoui, F., Vazeille, M., and Failloux, A.B. (2016). French Aedes albopictus are able to transmit yellow fever virus. Euro Surveill., 21.","DOI":"10.2807\/1560-7917.ES.2016.21.39.30361"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41564-019-0376-y","article-title":"Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus","volume":"4","author":"Kraemer","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Hamrick, P.N., Aldighieri, S., Machado, G., Leonel, D.G., Vilca, L.M., Uriona, S., and Schneider, M.C. (2017). Geographic patterns and environmental factors associated with human yellow fever presence in the Americas. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005897"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Kupferschmidt, K. (2016). After 40 years, the most important weapon against mosquitoes may be failing. Science.","DOI":"10.1126\/science.aal0254"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Moyes, C.L., Vontas, J., Martins, A.J., Ng, L.C., Koou, S.Y., Dusfour, I., Raghavendra, K., Pinto, J., Corbel, V., and David, J.-P. (2017). Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005625"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41579-018-0025-0","article-title":"Controlling vector-borne diseases by releasing modified mosquitoes","volume":"16","author":"Flores","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nbt.2350","article-title":"Successful suppression of a field mosquito population by sustained release of engineered male mosquitoes","volume":"30","author":"Harris","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_245","first-page":"395","article-title":"Tiger mosquitoes tackled in a trial","volume":"65","author":"Armbruster","year":"2019","journal-title":"Nature"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Zheng, X., Zhang, D., Li, Y., Yang, C., Wu, Y., Liang, X., Liang, Y., Pan, X., Hu, L., and Sun, Q. (2019). Incompatible and sterile insect techniques combined eliminate mosquitoes. Nature.","DOI":"10.1038\/s41586-019-1407-9"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41564-018-0268-6","article-title":"Control of dengue virus in the midgut of Aedes aegypti by ectopic expression of the dsRNA-binding protein Loqs2","volume":"3","author":"Olmo","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41586-018-0692-z","article-title":"Improved reference genome of Aedes aegypti informs arbovirus vector control","volume":"563","author":"Matthews","year":"2018","journal-title":"Nature"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Matthews, B.J., McBride, C.S., DeGennaro, M., Despo, O., and Vosshall, L.B. (2016). The neurotranscriptome of the Aedes aegypti mosquito. BMC Genomics, 17.","DOI":"10.1186\/s12864-015-2239-0"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/10\/960\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:17Z","timestamp":1760189237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/10\/960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":249,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["v11100960"],"URL":"https:\/\/doi.org\/10.3390\/v11100960","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]}}}